These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 22638108)
1. Early to intermediate steps of tumor embolic formation involve specific proteolytic processing of E-cadherin regulated by Rab7. Ye Y; Gao JX; Tian H; Yearsley K; Lange AR; Robertson FM; Barsky SH Mol Cancer Res; 2012 Jun; 10(6):713-26. PubMed ID: 22638108 [TBL] [Abstract][Full Text] [Related]
2. The genesis and unique properties of the lymphovascular tumor embolus are because of calpain-regulated proteolysis of E-cadherin. Ye Y; Tian H; Lange AR; Yearsley K; Robertson FM; Barsky SH Oncogene; 2013 Mar; 32(13):1702-13. PubMed ID: 22580607 [TBL] [Abstract][Full Text] [Related]
3. E-cadherin accumulation within the lymphovascular embolus of inflammatory breast cancer is due to altered trafficking. Ye Y; Tellez JD; Durazo M; Belcher M; Yearsley K; Barsky SH Anticancer Res; 2010 Oct; 30(10):3903-10. PubMed ID: 21036701 [TBL] [Abstract][Full Text] [Related]
4. An intact overexpressed E-cadherin/alpha,beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma. Tomlinson JS; Alpaugh ML; Barsky SH Cancer Res; 2001 Jul; 61(13):5231-41. PubMed ID: 11431364 [TBL] [Abstract][Full Text] [Related]
5. Geometric tumor embolic budding characterizes inflammatory breast cancer. Modi AP; Nguyen JPT; Wang J; Ahn JS; Libling WA; Klein JM; Mazumder P; Barsky SH Breast Cancer Res Treat; 2023 Feb; 197(3):461-478. PubMed ID: 36473978 [TBL] [Abstract][Full Text] [Related]
6. Relationship of sialyl-Lewis(x/a) underexpression and E-cadherin overexpression in the lymphovascular embolus of inflammatory breast carcinoma. Alpaugh ML; Tomlinson JS; Ye Y; Barsky SH Am J Pathol; 2002 Aug; 161(2):619-28. PubMed ID: 12163386 [TBL] [Abstract][Full Text] [Related]
7. Initiation of tumor dormancy by the lymphovascular embolus. Ye Y; Wang J; Izban MG; Ballard BR; Barsky SH Oncotarget; 2024 Oct; 15():726-740. PubMed ID: 39392391 [TBL] [Abstract][Full Text] [Related]
8. Reversible model of spheroid formation allows for high efficiency of gene delivery ex vivo and accurate gene assessment in vivo. Alpaugh ML; Barsky SH Hum Gene Ther; 2002 Jul; 13(10):1245-58. PubMed ID: 12133277 [TBL] [Abstract][Full Text] [Related]
9. Cooperative role of E-cadherin and sialyl-Lewis X/A-deficient MUC1 in the passive dissemination of tumor emboli in inflammatory breast carcinoma. Alpaugh ML; Tomlinson JS; Kasraeian S; Barsky SH Oncogene; 2002 May; 21(22):3631-43. PubMed ID: 12032865 [TBL] [Abstract][Full Text] [Related]
10. The lymphovascular embolus of inflammatory breast cancer exhibits a Notch 3 addiction. Xiao Y; Ye Y; Zou X; Jones S; Yearsley K; Shetuni B; Tellez J; Barsky SH Oncogene; 2011 Jan; 30(3):287-300. PubMed ID: 20838375 [TBL] [Abstract][Full Text] [Related]
11. Cadmium induces N-cadherin cleavage via ERK-mediated γ-secretase activation in C6 astroglia cells. Jo C; Koh YH Toxicol Lett; 2013 Oct; 222(2):117-21. PubMed ID: 23876460 [TBL] [Abstract][Full Text] [Related]
12. Function of Integrin-Linked Kinase in Modulating the Stemness of IL-6-Abundant Breast Cancer Cells by Regulating γ-Secretase-Mediated Notch1 Activation in Caveolae. Hsu EC; Kulp SK; Huang HL; Tu HJ; Salunke SB; Sullivan NJ; Sun D; Wicha MS; Shapiro CL; Chen CS Neoplasia; 2015 Jun; 17(6):497-508. PubMed ID: 26152358 [TBL] [Abstract][Full Text] [Related]
13. Nicastrin regulates breast cancer stem cell properties and tumor growth in vitro and in vivo. Lombardo Y; Filipović A; Molyneux G; Periyasamy M; Giamas G; Hu Y; Trivedi PS; Wang J; Yagüe E; Michel L; Coombes RC Proc Natl Acad Sci U S A; 2012 Oct; 109(41):16558-63. PubMed ID: 23012411 [TBL] [Abstract][Full Text] [Related]
14. Breast carcinomatous tumoral emboli can result from encircling lymphovasculogenesis rather than lymphovascular invasion. Mahooti S; Porter K; Alpaugh ML; Ye Y; Xiao Y; Jones S; Tellez JD; Barsky SH Oncotarget; 2010 Jun; 1(2):131-147. PubMed ID: 21297224 [TBL] [Abstract][Full Text] [Related]
15. A CBP binding transcriptional repressor produced by the PS1/epsilon-cleavage of N-cadherin is inhibited by PS1 FAD mutations. Marambaud P; Wen PH; Dutt A; Shioi J; Takashima A; Siman R; Robakis NK Cell; 2003 Sep; 114(5):635-45. PubMed ID: 13678586 [TBL] [Abstract][Full Text] [Related]
16. Gain in cellular organization of inflammatory breast cancer: A 3D in vitro model that mimics the in vivo metastasis. Morales J; Alpaugh ML BMC Cancer; 2009 Dec; 9():462. PubMed ID: 20028562 [TBL] [Abstract][Full Text] [Related]
17. Paradoxical E-cadherin increase in 5FU-resistant colon cancer is unaffected during mesenchymal-epithelial reversion induced by γ-secretase inhibition. Dinicola S; Pasqualato A; Proietti S; Masiello MG; Palombo A; Coluccia P; Canipari R; Catizone A; Ricci G; Harrath AH; Alwasel SH; Cucina A; Bizzarri M Life Sci; 2016 Jan; 145():174-83. PubMed ID: 26746659 [TBL] [Abstract][Full Text] [Related]
18. RUNX2 and TAZ-dependent signaling pathways regulate soluble E-Cadherin levels and tumorsphere formation in breast cancer cells. Brusgard JL; Choe M; Chumsri S; Renoud K; MacKerell AD; Sudol M; Passaniti A Oncotarget; 2015 Sep; 6(29):28132-50. PubMed ID: 26320173 [TBL] [Abstract][Full Text] [Related]
19. Calsenilin regulates presenilin 1/γ-secretase-mediated N-cadherin ε-cleavage and β-catenin signaling. Jang C; Choi JK; Na YJ; Jang B; Wasco W; Buxbaum JD; Kim YS; Choi EK FASEB J; 2011 Dec; 25(12):4174-83. PubMed ID: 21852538 [TBL] [Abstract][Full Text] [Related]
20. Presenilin 1/gamma-secretase is associated with cadmium-induced E-cadherin cleavage and COX-2 gene expression in T47D breast cancer cells. Park CS; Kim OS; Yun SM; Jo SA; Jo I; Koh YH Toxicol Sci; 2008 Dec; 106(2):413-22. PubMed ID: 18791180 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]